INTERNATIONAL PATENT: HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD., 杭州天龙药业有限公司 FILES APPLICATION FOR "SIRNA FOR TARGETED REGULATION OF PCSK9 GENE EXPRESSION AND USE THEREOF"

GENEVA, May 16 -- HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD. (No.430, Jianding Road, Shangcheng DistrictHangzhou, Zhejiang 310009), 杭州天龙药业有限公司 (中国浙江省杭州市上城区笕丁路430号) filed a patent application (PCT/CN2024/082133) for "SIRNA FOR TARGETED REGULATION OF PCSK9 GENE EXPRESSION, AND USE THEREOF" on Mar 18, 2024. With publication no. WO/2025/097633, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Prope...